McAdams Wright Ragen’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$2.47M Sell
38,144
-11,527
-23% -$730K 0.14% 129
2014
Q2
$3.09M Sell
49,671
-1,760
-3% -$105K 0.17% 116
2014
Q1
$3.03M Sell
51,431
-9,315
-15% -$520K 0.19% 104
2013
Q4
$3.1M Sell
60,746
-3,972
-6% -$199K 0.2% 104
2013
Q3
$3.26M Sell
64,718
-526
-0.8% -$27.5K 0.26% 87
2013
Q2
$3.21M Buy
+65,244
New +$3.55M 0.26% 104

Other funds holding LLY

McAdams Wright Ragen's LLY Position: Q3 2014 in Review

McAdams Wright Ragen reduced its Eli Lilly (LLY) stake by 23% in Q3 2014, selling an estimated $730K and leaving 38,144 shares worth $2.47M. The position accounts for 0.14% of the portfolio, ranked #129.

McAdams Wright Ragen first reported a position in LLY in Q2 2013 and has held it in 6 quarters since. The position peaked at $3.26M in Q3 2013. 1,040 funds tracked by Wall St. Rank hold LLY as of Q3 2014.

  • McAdams Wright Ragen held 38,144 shares of Eli Lilly worth $2.47M as of Q3 2014.
  • McAdams Wright Ragen sold 11,527 Eli Lilly shares in Q3 2014, an estimated $730K.
  • Eli Lilly made up 0.14% of McAdams Wright Ragen's portfolio in Q3 2014, its #129 holding.
  • McAdams Wright Ragen first reported a position in Eli Lilly in Q2 2013 and has held it in 6 quarters since.
  • McAdams Wright Ragen's Eli Lilly position peaked at $3.26M in Q3 2013.
  • 1,040 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2014.

Based on McAdams Wright Ragen's 13F filing for Q3 2014, filed 14 Nov 2014.